BI 894999 (R/R)

BI 894999 (R/R)

An Open Label, Phase Ia/Ib Dose Finding Study With BI 894999 Orally Administered Once a Day in Patients With Advanced Malignancies, With Repeated Administration in Patients With Clinical Benefit


Study Treatments


Inclusion criteria


Exclusion criteria


Participating sites

Link